Phase I/II study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with CML
4 months ago
[{"url":"https://i.ytimg.com/vi/sAVClpg3KJs/hq720.jpg?sqp=-oaymwEcCOgCEMoBSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLALHqwmq38v95AKK-s9FShvWpX7IA","width":360,"height":202},{"url":"https://i.ytimg.com/vi/sAVClpg3KJs/hq720.jpg?sqp=-oaymwEcCNAFEJQDSFXyq4qpAw4IARUAAIhCGAFwAcABBg==&rs=AOn4CLD8e_0kBZ9B8yyfRuOIz57Ru78yNQ","width":720,"height":404}]
{"url":"https://i.ytimg.com/an_webp/sAVClpg3KJs/mqdefault_6s.webp?du=3000&sqp=CL-9sKkG&rs=AOn4CLDWU6DNljmgTSooVHz3lmDMoCqlCw","width":320,"height":180}
[{"text":"Erica Brivio, MD, Princess M\u00e1xima Center for Pediatric Oncology, Utrecht, Netherlands, comments on the results of a Phase I/II\u00a0..."}]
{"name":"VJHemOnc \u2013 Video Journal of Hematological Oncology","id":"UCsQXL4_zTA-FoG9RA1tEGiw","thumbnails":[{"url":"https://yt3.ggpht.com/tLfkaYbACnFuAto-jU_XMyorvysy280aW3Kj1oDAKOH7nd58XYlz5rEL24x9ScNjruMr2YYw9w=s68-c-k-c0x00ffffff-no-rj","width":68,"height":68}],"link":"https://www.youtube.com/channel/UCsQXL4_zTA-FoG9RA1tEGiw"}
{"title":"Phase I/II study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with CML by VJHemOnc \u2013 Video Journal of Hematological Oncology 35 views 4 months ago 1 minute, 4 seconds","duration":"1 minute, 4 seconds"}